Neurobiology of Aging
Journal
Overview
publication venue for
-
Effects of estrogen and aging on synaptic morphology and distribution of phosphorylated Tyr1472 NR2B in the female rat hippocampus.
73:200-210.
2019
-
Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease.
65:201-205.
2018
-
Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models.
44:159-172.
2016
-
Resveratrol attenuates peripheral and brain inflammation and reduces ischemic brain injury in aged female mice.
44:74-84.
2016
-
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.
37:47-57.
2016
-
Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats.
36:505-18.
2015
-
Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain.
36:2972-83.
2015
-
Periodontal disease associates with higher brain amyloid load in normal elderly.
36:627-33.
2015
-
The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.
35:1318-1324.
2014
-
Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.
35:1162-76.
2014
-
Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.
35:64-71.
2014
-
Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.
34:1581-8.
2013
-
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with alzheimer's parents.
34:22-34.
2013
-
Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: Their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
33:2641-60.
2012
-
Whole brain N-acetylaspartate concentration is conserved throughout normal aging.
33:2440-7.
2012
-
Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.
33:1215-1227.
2012
-
Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation.
33:1121.e13-24.
2012
-
Nonlinear time course of brain volume loss in cognitively normal and impaired elders.
33:845-55.
2012
-
Accumulation of resident and peripheral dendritic cells in the aging CNS.
33:681-693.e1.
2012
-
Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.
33:827.e11-9.
2012
-
Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.
33:624.e1-9.
2012
-
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.
32:2131-2141.
2011
-
Structural brain changes in normal individuals with a maternal history of Alzheimer's.
32.
2011
-
Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses.
31:1145-52.
2010
-
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal.
31:1077-1088.
2010
-
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
30:1728-36.
2009
-
Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.
30:1587-600.
2009
-
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.
30:682-690.
2009
-
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.
30:672-681.
2009
-
Enhanced and bilateralized visual sensory processing in the ventral stream may be a feature of normal aging.
29:1576-86.
2008
-
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
29:836-847.
2008
-
Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophages.
29:707-15.
2008
-
Hippocampal hypometabolism predicts cognitive decline from normal aging.
29:676-692.
2008
-
Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect.
29:95-101.
2008
-
Imaging markers of mild cognitive impairment: Multivariate analysis of CBF SPECT.
28:1062-9.
2007
-
Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration.
27:983-93.
2006
-
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.
27:394-401.
2006
-
Somatic mitochondrial DNA mutations in single neurons and glia.
26:1343-55.
2005
-
Subjective memory complaints in aging are associated with elevated cortisol levels.
26:1357-63.
2005
-
Mitochondrial function in fibroblasts with aging in culture and/or Alzheimer's disease.
26:839-48.
2005
-
Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: Replicability of regional differences in volume.
25:377-96.
2004
-
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.
25:71-81.
2004
-
Aβ42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3β signaling-dependent mechanism.
24:437-51.
2003
-
Age-related differences in brain activation during emotional face processing.
24:285-95.
2003
-
Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury.
23:31-9.
2002
-
Hippocampal formation glucose metabolism and volume losses in MCI and AD.
22:529-39.
2001
-
Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest.
21:829-36.
2000
-
Age-related differences in visual perception: A PET study.
21:577-84.
2000
-
Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease.
21:19-26.
2000
-
Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.
18:131-8.
1997
-
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease.
18:1-11.
1997
-
Neurofibrillary pathology - Correlation with hippocampal formation atrophy in Alzheimer disease.
17:909-19.
1996
-
Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade.
16:5-10.
1995
-
Huntington's disease, energy, and excitotoxicity.
15:275-6.
1994
-
Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: A Stereological estimate of neuronal loss.
14:295-301.
1993
-
Neurochemical aspects of aging in primates.
14:707-9.
1993
-
In vivo neurotoxicity of beta-amyloid [β(1-40)] and the β(25-35) fragment.
13:537-42.
1992
-
Resting [Ca2+]i and [Ca2+]i transients are similar in fibroblasts from normal and Alzheimer's donors.
13:33-8.
1992
-
Neurotransmitters in neocortex of aged rhesus monkeys.
12:407-12.
1991
-
Will neurotrophic agents be harmful in Alzheimer's disease?.
10:580-1; discussion 588-90.
1989
-
Age-related disruption of classical conditioning: A model systems approach to memory disorders.
9:535-46.
1988
-
Positron emission tomography with the deoxyglucose technique and the diagnosis of Alzheimer's disease.
9:88-90.
1988
-
Positron emission tomography studies of normal aging: A replication of PET III and 18-FDG using PET VI and 11-CDG.
8:319-23.
1987
-
Is a breakdown of the blood-brain barrier cause or effect?.
7:512-514.
1986
-
Reduced incidence of left-handedness in clinically diagnosed dementia of the Alzheimer type.
7:161-4.
1986
-
Structural and functional neuroimaging in Alzheimer's disease.
7:396-398.
1986
-
Central amine metabolism in Alzheimer's disease: In vivo relationship to cognitive deficit.
2:57-60.
1981
-
Computed tomography evaluations of brain-behavior relationships in senile d dementia of the Alzheimer's type.
1:69-79.
1980
-
Positron Emission Tomography in the Study of Aging and Senile Dementia.
1:127-31.
1980
-
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia
2006
-
Cholesterol in neurologic disorders of the elderly: Stroke and Alzheimer's disease
2004
-
Biological markers for therapeutic trials in Alzheimer's disease: Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease
2003
-
Energy, oxidative damage, and Alzheimer's disease: Clues to the underlying puzzle
1994
-
Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment
2005
-
Oxidative stress in Alzheimer's disease
2005
Identity
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)